{"title":"Sirolimus","summary":"Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumor (PEComa).[1][2][7][8] It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants. It is a mechanistic target of rapamycin kinase (mTOR) inhibitor[2] that inhibits activation of T cells and B cells by reducing their sensitivity to interleukin-2 (IL-2).[9]","image":"Sirolimus_structure.svg.png.webp","url":"Sirolimus"}